Clinical Trials Sponsored by Inventiva Pharma

Total 8351 results

Inventiva Pharma

Active, not recruiting

Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus (LEGEND)

Diabetes Mellitus, Type 2 | NASH - Nonalcoholic Steatohepatitis

United States, Belgium, France, Netherlands, United Kingdom
Inventiva Pharma

Completed

A Study in MPS VI to Assess Safety and Efficacy of Odiparcil (iMProveS)

Mucopolysaccharidosis VI

United Kingdom, France, Germany, Portugal
Inventiva Pharma

Completed

Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis (FASST)

Scleroderma, Diffuse | Diffuse Cutaneous Systemic Sclerosis

United Kingdom, France, Spain, Switzerland, Italy, Slovenia, Netherlands, Germany, Bulgaria, Poland
Inventiva Pharma

Recruiting

A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) (NATiV3)

NASH - Nonalcoholic Steatohepatitis

United States, Argentina, Australia, Austria, Belgium, France, Germany, Israel, Portugal, Spain, United Kingdom, Canada, Italy, China, Brazil, Netherlands, Hungary, Bulgaria, Chile, Czechia, Mexico, Poland, Puerto Rico, South Africa, Uk...
Inventiva Pharma

Completed

Phase 2b Study in NASH to Assess IVA337 (NATIVE)

Non-Alcoholic Steatohepatitis (NASH)

United States, Spain, United Kingdom, France, Belgium, Austria, Switzerland, Australia, Germany, Slovenia, Bulgaria, Canada, Czechia, Italy, Mauritius, Poland
Inventiva Pharma
Parexel

Completed

Multiple Ascending Dose Phase I Study in Order to Define Lanifibranor (IVA337) Supra-thjerapeutic Dose (MAD)

Healthy Subjects

Germany
University of Florida
Inventiva Pharma

Completed

Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease

Nonalcoholic Fatty Liver Disease (NAFLD) | Type 2 Diabetes (T2DM)

United States
Prism Pharma Co., Ltd.
inVentiv Health Clinical

Completed

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies

Acute Myeloid Leukemia | Chronic Myeloid Leukemia

United States
Prism Pharma Co., Ltd.
inVentiv Health Clinical

Completed

Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma | Metastatic Pancreatic Cancer | Advanced Pancreatic Cancer

United States
Prism Pharma Co., Ltd.
inVentiv Health Clinical

Terminated

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

United States
Circassia Limited
inVentiv Health Clinical; Pharm-Olam International

Completed

Phase III Cat-PAD Study

Rhinoconjunctivitis

United States, Poland, Germany, Belgium, Canada, Russian Federation, Hungary, Slovakia, Czechia
Aptinyx
inVentiv Health Clinical

Completed

Evaluate the Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia

Fibromyalgia

United States
Kedrion S.p.A.
inVentiv Health Clinical

Terminated

Safety Study of Kedbumin 25% Versus Normal Saline in the Treatment of Post-Surgical Hypovolemia in Pediatric Patients

Hypovolemia

United States
Circassia Limited
inVentiv Health Clinical

Completed

Paediatric Safety Study in Cat-PAD

Rhinoconjunctivitis

Poland
Gelesis, Inc.
inVentiv Health Clinical

Completed

Gelesis Glycemic Index Study (GLIDE)

Obesity | Diabetes | PreDiabetes

Canada
Aquestive Therapeutics
Covance; Inventiv Health

Withdrawn

Riluzole Oral Soluble Film Safety and Tolerability in Amyotrophic Lateral Sclerosis

ALS

United States
Unidade de Terapia Intensiva

Unknown

Septic Shock em Steroids

Mortality | Mechanical Ventilation

Brazil
GlaxoSmithKline
Monash University; InVentiv Clinique

Terminated

Comparison of Inhaled Oxytocin (IH) With Intramuscular (IM) Oxytocin in Pregnant Women and With Intravenous (IV) Oxytocin in Healthy Non-pregnant Women

Postpartum Hemorrhage

Australia, United Kingdom
Aquestive Therapeutics
Covance; inVentiv Health Clinical

Completed

Study of Diazepam Buccal Film Administered in the Interictal and in the Ictal-Periictal States to Adults With Epilepsy

Epilepsy

United States
Clarus Therapeutics, Inc.
inVentiv Health Clinical

Completed

Safety and Efficacy Trial of Testosterone Undecanoate

Male Hypogonadism

United States
Aquestive Therapeutics
Covance; inVentiv Health Clinical

Terminated

Riluzole Oral Soluble Film (ROSF) Swallowing Safety in Amyotrophic Lateral Sclerosis (ALS) (ROSF)

Amyotrophic Lateral Sclerosis

United States
Adello Biologics, LLC
inVentiv Health Clinical

Completed

Study Comparing TPI-120 and Neulasta Administered Through Subcutaneous Route in Healthy Adult Subjects (TPI-120)

Healthy Volunteers

United States
Unidade de Terapia Intensiva

Unknown

Norepinephrine as Early Vasopressor Therapy in Children Undergoing Mechanical Ventilation

Shock | Mechanical Ventilation

Brazil
R-Pharm
Covance; Cromos Pharma LLC

Withdrawn

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

COVID-19
Grupo Mexicano para el Estudio de la Medicina Intensiva

Completed

In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection

COVID-19

Mexico
Grupo Mexicano para el Estudio de la Medicina Intensiva

Completed

Ultrasound Meal Accommodation Test for Enteral Feeding in the Critically Ill (UMATI)

Enteral Feeding Intolerance

Mexico
Synermore Biologics Co., Ltd.
inVentiv Health Clinical

Completed

A Comparison of the Safety, PD and PK of a Single Dose of SYN023 Administered With Licensed Rabies Vaccines (RabiesMab)

Human Rabies

United States
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056

Rheumatoid Arthritis

United States, Belgium, United Kingdom
AJU Pharm Co., Ltd.
OM Pharma SA

Recruiting

The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Chronic Prostatitis | Chronic Pelvic Pain Syndrome

Korea, Republic of
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Japan, Korea, Republic of, Taiwan
Yuria-Pharm
Pharmaxi LLC

Completed

Epidemiological Study of the COVID-2019 in Participating Organizations.

Covid19

Ukraine
Bristol-Myers Squibb
inVentiv Health Clinical; PharmaNet

Completed

Long-term Experience With Abatacept SC in Routine Clinical Practice (ASCORE)

Rheumatoid Arthritis

Spain, France, Italy, United Kingdom, Greece, Australia, Austria, Germany, Monaco, Netherlands, Switzerland
Associação Fundo de Incentivo à Pesquisa

Completed

Obstructive Sleep Apnea and Telomere Length

Obstructive Sleep Apnea

Brazil
Associação Fundo de Incentivo à Pesquisa

Completed

Continuous Positive Airway Pressure and Oral Appliances Treatments in Mild Obstructive Sleep Apnea (OSAS)

Mild Obstructive Sleep Apnea Syndrome

Brazil
Associação Fundo de Incentivo à Pesquisa

Unknown

Donepezil, Residual Excessive Daytime Sleepiness, Obstructive Sleep Apnea

OSA | Sleepiness

Brazil
Associação Fundo de Incentivo à Pesquisa

Unknown

Efficacy of Oral Appliance for Upper Airway Resistance Syndrome

Upper Airway Resistance Syndrome

Brazil
Associação Fundo de Incentivo à Pesquisa

Completed

Phonoaudiologic Therapy Adjunct to Treatment on Patients With Obstructive Sleep Apnea

Obstructive Sleep Apnea Syndrome

Brazil
Associação Fundo de Incentivo à Pesquisa

Completed

Epidemiology of Sleep Disturbances Among the Adult Population of the Sao Paulo City

Healthy

Brazil
Associação Fundo de Incentivo à Pesquisa

Unknown

Cost-utility Study of Continuous Positive Airway Pressure Treatment in Obstructive Sleep Apnea Syndrome Patients

Obstructive Sleep Apnea Syndrome

Brazil
Associacao Fundo de Incentivo a Psicofarmcologia

Unknown

Titration of Continuous Positive Airway Pressure Could Predict Success of Oral Appliance to Treat Sleep Apnea

Obstructive Sleep Apnea

Brazil
Associação Fundo de Incentivo à Pesquisa

Terminated

Acute Effects of Gabapentin in Sleep Parameters and Hormonal Release During Sleep in Older Men

Sleep

Brazil
Associação Fundo de Incentivo à Pesquisa

Completed

Late-onset Congenital Central Hypoventilation Syndrome and the Mutation of Phox2B Gene (CCHS)

Congenital Central Hypoventilation Syndrome

Brazil
Associação Fundo de Incentivo à Pesquisa

Unknown

Bedside Sleep Medicine

Sleep Apnea | Acute Decompensated Heart Failure | Sleep Disorders | Acute Myocardial Infarction

Brazil
Associação Fundo de Incentivo à Pesquisa

Unknown

Heart Failure and Sleep Apnea: Exercise Training and Continuous Positive Airway Pressure (CPAP)

Heart Failure | Sleep Apnea Syndromes

Brazil
Associação Fundo de Incentivo à Pesquisa

Completed

Left Atrial Volume and Function Evaluation in Patients With Obstructive Sleep Apnea

Sleep Apnea Syndromes

Brazil
Associação Fundo de Incentivo à Pesquisa

Completed

Structural and Functional Left Ventricular Remodelling in Patients With Obstructive Sleep Apnea

Obstructive Sleep Apnea

Brazil
Associacao Fundo de Incentivo a Psicofarmcologia

Unknown

Cardiovascular Risk Stratification in Patients With Obstructive Sleep Apnea (ERA)

Obesity | Obstructive Sleep Apnea

Brazil
Holy Stone Healthcare Co., Ltd
inVentiv Health Clinical

Completed

A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M

Colitis, Ulcerative

Italy
Associação Fundo de Incentivo à Pesquisa

Unknown

Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19

Covid19 | Lung Injury
Associação Fundo de Incentivo à Pesquisa

Completed

Genetic and Physiological Aspects of Oxidative Profile in Sleep and Well-succeed Aging

Aging; Without Mention of Psychosis

Brazil

Clinical Trials Sponsored by Inventiva Pharma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations